H5N1 influenza viral lineages beginning to evade human immunological defenses, research finds
New computational modeling of avian influenza variants' immunoprotein interactions—developed by a research team at the ...
New understanding of B cell mutation strategies could have implications for vaccines
A vaccine's ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a ...
News-Medical.Net on MSN4h
Study reveals how B cells safeguard high-affinity antibodies
A vaccine's ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a vaccine or pathogen, B cells scramble to refine their defenses, rapidly mutating ...
Technology Networks22h
New Insights Into B Cell Mutations Could Improve Vaccine Strategies
Successful high-affinity B cells can proliferate under special conditions that reduce the risk of mutation. Capturing this ...
Q4 2024 OmniAb Inc Earnings Call
Kurt Gustafson; Chief Financial Officer, Executive Vice President - Finance; OmniAb Inc. Matthew Foehr; President, Chief Executive Officer, Director; OmniAb Inc. Joe ...
INOVIO Pharmaceuticals, Inc.: INOVIO Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
Significant progress toward submitting a biologics license application (BLA) for INO-3107 as a potential treatment for recurrent respiratory papillomatosis (RRP) ...
OmniAb, Inc. (OABI) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Conference Call March 18, 2025 4:30 PM ETCompany ParticipantsKurt Gustafson - Chief Financial OfficerMatt ...
pharmaphorum22h
Artificial Intelligence for better antibody drugs: ready for prime time?
The potential of monoclonal antibodies (mAbs) as therapies is indisputable. The current mAbs market is expected to be around ~USD 150 billion. In 2021, five out of the top 10 selling drugs were ...